Joint Estimation of Remission and Response for Methotrexate‐Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta‐Analysis

OBJECTIVE: To jointly estimate American College of Rheumatology (ACR50) response (a more commonly reported outcome) and remission (a more clinically relevant outcome) for methotrexate (MTX)‐based treatment options in rheumatoid arthritis (RA). METHODS: We conducted a bivariate network meta‐analysis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACR Open Rheumatol
Autors principals: Pokharel, Gyanendra, Deardon, Rob, Barnabe, Cheryl, Bykerk, Vivian, Bartlett, Susan J, Bessette, Louis, Boire, Gilles, Hitchon, Carol A, Keystone, Edward, Pope, Janet, Schieir, Orit, Tin, Diane, Thorne, Carter, Hazlewood, Glen S, Baron, Murray, Colmegna, Ines, Fallavollita, Sabrina, Haaland, Derek, Haraoui, Paul, Hazlewood, Glen, Hitchon, Carol, Jamal, Shahin, Joshi, Raman, Keystone, Ed, Nair, Bindu, Panopoulos, Peter, Penney, Christopher, Rubin, Laurence, Villeneuve, Edith, Zummer, Michel
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858043/
https://ncbi.nlm.nih.gov/pubmed/31777827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr2.11052
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars